Skip to main content
. 2022 Jan 29;23(3):1566. doi: 10.3390/ijms23031566
ACLT Anterior Cruciate Ligament Transection
ATC Anatomical Therapeutic Chemical Classification System
AAOS The American Academic of Orthopaedic Surgeons
ACR The American College of Rheumatology
BDNF Brain-Derived Neurotrophic Factor
BMP Bone Morphogenetic Proteins
CBx Cannabinoid Receptors Type x
CDC kinaze x Cyclin-Dependent Kinase Type x
CTGF Connective Tissue Growth Factor
DMOAD Disease-Modifying Drugs for Osteoarthritis
EGF Epidermal Growth Factor
EMA The European Medicines Agency
EULAR The European League Against Rheumatism
FDA The US Food and Drug Administration
FGF Fibroblast Growth Factor
GF Growth Factor
GS Glucocorticosteroid
HA Hyaluronic Acid
HGF Hepatocyte Growth Factor
IA HA Intra-Articular Hyaluronic Acid
IGF Insulin-Like Growth Factor
IL-x Interleukin Type x
IFN-γ Interferons Type II
IP-10 Interferon-Γ-Inducible Protein 10, CXCL10
OA Osteoarthritis
NT-x Neurotrophin Type x
NFG Nerve Growth Factor
NF-κB Nuclear Factor of Kappa Light Chain Enhancer of Activated B Cells
NSAID Non-Steroidal Anti-Inflammatory Drugs
MIBO Minimum Information for Studies Evaluating Biologics in Orthopedics
MFAT Micro-Fragmented Adipose Tissue
MMP-9 Matrix Metalloproteinase-9
OARSI The Osteoarthritis Research Society International
PDGF Platelet-Derived Growth Factor
PLT Platelets
PPI Proton Pump Inhibitors
PRF Platelet-Rich Fibrin
PRP Platelet-Rich Plasma
PsA Psoriatic Arthritis
RCT Randomized Controlled Trials
RANK-L Receptor Activator for Nuclear Factor Κ B Ligand
RA Rheumatoid Arthritis
SA Septic Arthritis
SMADx The SMAD type x Transcription Factors; The SMAD is an acronym from The Fusion Of Caenorhabditis Elegans Sma Genes And The Drosophila Mad, Mothers Against Decapentaplegic
SYSADOA Symptomatic Slow-Acting Drugs For Osteoarthritis
TGF-x Transforming Growth Factor Type x
TNFx Tumor Necrosis Factor Type x
WOMAC Western Ontario And McMaster Universities Osteoarthritis Index
Wnt Wingless-Like Glycoproteins
VEGF Vascular Endothelial Growth Factor